| Product Code: ETC13117588 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Ivory Coast continued to import pneumococcal vaccines primarily from Italy, France, Denmark, India, and Argentina. The Herfindahl-Hirschman Index (HHI) indicated moderate concentration within the market. With a compound annual growth rate (CAGR) of 4.83% from 2020 to 2024 and a growth rate of 1.73% in 2023-24, the market for pneumococcal vaccines in Ivory Coast is showing steady growth. This data suggests a sustained demand for these vaccines in the country, potentially driven by increasing awareness of the importance of immunization in public health.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cote D'Ivore Pneumococcal Vaccines Market Overview |
3.1 Cote D'Ivore Country Macro Economic Indicators |
3.2 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Cote D'Ivore Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Cote D'Ivore Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Cote D'Ivore Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and government initiatives for immunization programs in Côte d'Ivoire |
4.2.2 Growing healthcare infrastructure and investment in vaccination campaigns |
4.2.3 Rising prevalence of pneumococcal diseases and the need for preventive measures |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines and limited access to healthcare services in rural areas |
4.3.2 Lack of adequate funding for vaccination programs and supply chain challenges |
4.3.3 Limited public health education on the benefits of pneumococcal vaccines |
5 Cote D'Ivore Pneumococcal Vaccines Market Trends |
6 Cote D'Ivore Pneumococcal Vaccines Market, By Types |
6.1 Cote D'Ivore Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Cote D'Ivore Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Cote D'Ivore Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Cote D'Ivore Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Cote D'Ivore Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Cote D'Ivore Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Cote D'Ivore Pneumococcal Vaccines Market Export to Major Countries |
7.2 Cote D'Ivore Pneumococcal Vaccines Market Imports from Major Countries |
8 Cote D'Ivore Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for pneumococcal vaccines in Côte d'Ivoire |
8.2 Number of healthcare facilities equipped to administer pneumococcal vaccines |
8.3 Reduction in the incidence rate of pneumococcal diseases in the population due to vaccination efforts |
9 Cote D'Ivore Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Cote D'Ivore Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cote D'Ivore Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Cote D'Ivore Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Cote D'Ivore Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Cote D'Ivore Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Cote D'Ivore Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Cote D'Ivore Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here